AEMD Aethlon Medical Inc

Price (delayed)

$2.17

Market cap

$2.85M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$51.89

Enterprise value

-$3.78M

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier ...

Highlights
The quick ratio has soared by 101% YoY and by 32% from the previous quarter
Aethlon Medical's EPS has surged by 59% YoY and by 13% QoQ
The net income has declined by 21% year-on-year and by 2.3% since the previous quarter

Key stats

What are the main financial stats of AEMD

AEMD stock price

How has the Aethlon Medical stock price performed over time
Intraday
3.33%
1 week
-26.19%
1 month
-9.58%
1 year
-92.58%
YTD
-21.66%
QTD
-0.91%

Financial performance

How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.37M
Net income
-$11.52M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 25% YoY but it fell by 3.5% QoQ
The net income has declined by 21% year-on-year and by 2.3% since the previous quarter

Price vs fundamentals

How does AEMD's price correlate with its fundamentals

Growth

What is Aethlon Medical's growth rate over time

Valuation

What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.25
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 59% YoY and by 13% QoQ
The P/B is 78% below the 5-year quarterly average of 1.1 and 60% below the last 4 quarters average of 0.6
The company's equity has surged by 55% YoY and by 17% QoQ

Efficiency

How efficient is Aethlon Medical business performance
Aethlon Medical's ROIC has plunged by 199% YoY and by 28% from the previous quarter
The ROA has plunged by 51% YoY but it has grown by 3.3% from the previous quarter
The ROE has contracted by 42% YoY but it has grown by 9% from the previous quarter

Dividends

What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AEMD.

Financial health

How did Aethlon Medical financials performed over time
Aethlon Medical's current ratio has surged by 103% YoY and by 28% QoQ
The quick ratio has soared by 101% YoY and by 32% from the previous quarter
The company's debt is 94% lower than its equity
The debt to equity has dropped by 65% year-on-year and by 33% since the previous quarter
The company's equity has surged by 55% YoY and by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.